Advertisement

Drugs in R & D

, Volume 5, Issue 3, pp 182–183 | Cite as

Tramadol — Biovail Corporation

Adis R&D Profile

Keywords

Tramadol Venlafaxine Mirtazapine Serotonin Syndrome Tramadol Hydrochloride 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Biovail Corporation. Biovail NDA For Ralivia ER — Tramadol Extended Release Tablets — Accepted for Review. Media Release: 26 Feb 2004. Available from URL: http://www.biovail.com Google Scholar
  2. 2.
    Biovail Corporation. Biovail Submits NDA for Ralivia Flash-Dose. Media Release: 11 Mar 2004. Available from URL: http://www.biovail.com Google Scholar
  3. 3.
    Houlihan DJ. Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine. Annals of Pharmacotherapy 38: 411–3, No. 3, Mar 2004PubMedCrossRefGoogle Scholar
  4. 4.
    Biovail Corporation. Biovail Presents Tramadol Results at American College of Rheumatology. Media Release: 28 Oct 2002. Available from URL: http://www.biovail.com Google Scholar
  5. 5.
    Biovail Corporation. Biovail reports second positive phase III clinical result for tramadol extended release formulation. Media Release [3 pages], 14 Jan 2002. Available from URL: http://www.biovail.com Google Scholar

Copyright information

© Adis Data Information BV 2004

Personalised recommendations